Proteins and Peptides

13 Jun 2017 Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
13 Jun 2017 ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
13 Jun 2017 Tresiba® demonstrated no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial
12 Jun 2017 Bioverativ Announces FDA Acceptance of Investigational New Drug Application for BIVV001 to Treat Hemophilia A
12 Jun 2017 Zealand to regain control of elsiglutide
12 Jun 2017 Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
12 Jun 2017 Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan
11 Jun 2017 Catalyst Biosciences Announces Presentations on its Next-Generation Subcutaneous Hemophilia Product Candidates at the 2017 International Society on Thrombosis and Haemostasis (ISTH) Meeting
11 Jun 2017 Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions
11 Jun 2017 Merz Neurosciences Announces Positive Phase III Results of Xeomin® (IncobotulinumtoxinA) for Sialorrhea at 2017 MDS Meeting
06 Jun 2017 Refixia® (nonacog beta pegol; N9-GP) approved
05 Jun 2017 Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
05 Jun 2017 Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO
04 Jun 2017 Endocyte Announces Clinical Updates for EC1456 and EC1169
04 Jun 2017 ARMO BioSciences Announces Encouraging Survival Data Observed in Patients with Advanced Pancreatic Cancer in Phase 1/1b Trial of Immunotherapy AM0010
04 Jun 2017 ARMO BioSciences Announces Promising Response Rates and Survival Data in Patients with Advanced NSCLC and RCC from Phase 1/1b Trial for Immunotherapy AM0010 with Checkpoint Inhibitors
04 Jun 2017 Pieris Pharmaceuticals Announces Presentation of Clinical Data for Anemia Drug Candidate, PRS-080, at the 54th ERA-EDTA Congress
02 Jun 2017 European Commission Approves Brineura™ (cerliponase alfa), the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children
01 Jun 2017 Novo Nordisk receives US FDA approval of REBINYN® (nonacog beta pegol; N9-GP)
30 May 2017 Molecular Partners provides additional details on clinical studies of proprietary lead oncology asset MP0250
28 May 2017 Novo Nordisk submits application in the US for including data from the DEVOTE trial in the Tresiba® label
26 May 2017 Protagonist Therapeutics Initiates Phase 1 Study with Novel Hepcidin Mimetic, PTG-300
26 May 2017 FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications
25 May 2017 Radius Announces Positive Top-Line Results from Completed ACTIVExtend Study for TYMLOS™ in Postmenopausal Women with Osteoporosis
24 May 2017 Spyryx Biosciences Reports Positive Data on SPX-101 at American Thoracic Society International Conference

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing